CD123 targeted CAR-NK cells
PBC050
Phase 2 mab active
Quick answer
CD123 targeted CAR-NK cells for Acute Myeloid Leukemia is a Phase 2 program (mab) at PRECISION BIOSCIENCES INC with 1 ClinicalTrials.gov record(s).
Program details
- Company
- PRECISION BIOSCIENCES INC
- Indication
- Acute Myeloid Leukemia
- Phase
- Phase 2
- Modality
- mab
- Status
- active